|
| 27/09/2004 |
INTERIM REPORT FOR THE SIX MONTHS ENDED 30 JUNE 2004 |
|
| 27/09/2004 |
ALIZYME GRANTED AUTHORISATION FOR PHASE IIb CLINICAL TRIAL |
|
| 24/09/2004 |
WEB CAST NOTIFICATION |
|
| 12/08/2004 |
INTERIM RESULTS NOTIFICATION for the six months ended 30 June 2004 |
|
| 03/06/2004 |
THE ANNUAL GENERAL MEETING : 2004 |
|
| 27/04/2004 |
AGM NOTIFICATION AND COMMENT |
|
| 01/04/2004 |
FINANCIAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2003 |
|
| 29/03/2004 |
PRELIMINARY RESULTS WEBCAST NOTIFICATION |
|
| 16/03/2004 |
PRELIMINARY RESULTS NOTIFICATION |
|
| 30/01/2004 |
TAKEDA EXERCISES RIGHTS TO LICENCE TO DEVELOP ALIZYME'S OBESITY DRUG FOR JAPAN |
|
| 12/01/2004 |
ALIZYME FILES NEW PATENT APPLICATION FOR RENZAPRIDE |
|
| 12/01/2004 |
ALIZYME SUCCESSFULLY COMPLETES CLINICAL TRIAL FOR RENZAPRIDE IN IRRITABLE BOWEL SYNDROME PATIENTS IN USA |
|
Help